Causal variants in Maturity Onset Diabetes of the Young (MODY) - A systematic review

Ibrar Rafique1,2,3, Asif Mir4, Muhammad Arif Nadeem Saqib5

  • 1Department of Biological Sciences, International Islamic University, Islamabad, Pakistan.

BMC Endocrine Disorders
|November 12, 2021
PubMed
Abstract

Insights

This study compiled 1017 known and 74 unpublished genetic variants causing Maturity Onset Diabetes of the Young (MODY). It aims to aid clinicians in interpreting MODY genetic test results more accurately.

Area of Science:

  • Genetics
  • Endocrinology
  • Molecular Biology

Background:

  • Maturity Onset Diabetes of the Young (MODY) is an autosomal dominant diabetes type with overlapping symptoms to types 1 and 2 diabetes.
  • While clinical reviews exist, a comprehensive catalog of causal genetic variants for MODY is absent.
  • This study addresses the need for a consolidated list of all identified MODY-causing variants.

Purpose of the Study:

  • To systematically collect and list all reported causal genetic variants associated with MODY.
  • To provide a comprehensive resource for understanding the genetic basis of MODY.
  • To support clinicians in interpreting genetic testing results for MODY.

Main Methods:

  • Conducted a comprehensive literature search of PubMed from inception to December 2019.
  • Included searches for disease names and all known MODY-associated genes.
  • Cross-referenced findings with the ClinVar database for causal variants in 14 known MODY genes.

Main Results:

  • Identified a total of 1017 variants from literature and 74 unpublished variants from ClinVar.
  • The GCK gene was most frequently implicated, followed by HNF1a.
  • Sanger sequencing was the predominant method (76%), with 65% of studies published in the last decade.

Conclusions:

  • The compiled variant list is expected to enhance clinician confidence in interpreting MODY genetic results.
  • Observed discrepancies in MODY prevalence in Middle Eastern countries warrant further investigation into potential genetic factors like consanguinity.

Related Concept Videos

Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.5K
Pathophysiology of Diabetes01:20

Pathophysiology of Diabetes

Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
2.0K
Diabetes Mellitus: Type 2 and Gestational01:22

Diabetes Mellitus: Type 2 and Gestational

Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
3.2K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
1.3K
Diabetes: Management and Pharmacotherapy01:15

Diabetes: Management and Pharmacotherapy

The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
536
Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
476